MoonLake Immunotherapeutics (MLTX) Sector
Health Care

(Current) $14.86
0.62 (4.35%) Open Price: 14.79

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company unlocking the potential of Sonelokimab, the novel investigational Nanobody® for the treatment of inflammation, to revolutionize outcomes for patients

(12/12/25) $14.79
(12/15/25) $14.24
(12/15/25) (Qty.)2,513,381
(12/12/25) $14.10
(12/12/25) $14.98
(10/12/25) $8.80
(12/07/25) $15.56
Stocktwits
LetsEncrypt SSL Secure Stripe Payment Processing